Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 25, No 7 (March 1), 2007: pp. 750
© 2007 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2007.11.0387

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Disis, M. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Disis, M. L.

EDITORIAL

Translational Oncology: Transforming Cancer Care

Mary L. Disis

Center for Translational Medicine in Women’s Health, University of Washington, Seattle, WA

More than any other discipline, oncology has been transformed by extraordinary scientific advancements that have occurred during the last decade. On a daily basis, we are thinking increasingly of cancer not by its particular pathologic features, but by its specific genetic alterations. The newest treatments are based on manipulating molecular targets present in a tumor rather than globally attempting to inhibit all cell growth. The pace at which bench-to-bedside research is having an impact on the clinical practice of oncology is extraordinary. It is an exciting and hopeful time to be involved in cancer research and care.

The explosion of new approaches in cancer therapy, diagnosis, prevention, and prediction of response leads to some interesting challenges. How can we keep informed of the myriad discoveries that will impact patient care in the near future? How can we learn about genetic pathways and environmental alterations occurring in cancer that are increasingly being exploited for clinical purpose? As the therapeutic road from the laboratory to the clinic shortens, our need for the most up-to-date information increases. Translational oncology has become mainstream oncology—it is what we do each day in the laboratory and in the clinic.

Over the last few years, the Journal of Clinical Oncology (JCO) has produced a series on translational oncology topics and original papers. The series was received with enthusiasm by our readers, as well as basic and clinical scientists who found JCO an ideal venue for the publication of their work. In acknowledgment of the seamless integration of translational oncology into cancer care, JCO has now integrated the translational oncology series into each issue. Cutting-edge research and review articles concerning the most important scientific advances influencing clinical practice are published side by side with randomized clinical trials that change current standards of care. This evolution of JCO will provide both the daily tools needed for clinical practice as well as an immediate future vision of the practice of oncology.

JCO welcomes novel research submissions from authors who have "one hand on the bench and the other on the patient." Original research in fields such as tumor immunology, genomics, proteomics, epigenetics, and angiogenesis represent the future of cancer care. Some examples of the types of research that JCO encourages for submission include:

  • Early phase studies that report an unusual clinical response or an unexpected adverse effect that speaks to the mechanism of an action, or studies that present novel biomarkers that contribute significantly to our understanding of a drug's effect;
  • Biomarkers, with biologic importance, that have been validated as useful clinical tools; and
  • Preclinical studies that address critical issues and bring insight to complex clinical problems.

If research results might impact oncology practice within the next few years, it is critical that JCO readers learn of the key findings.

As practitioners who care for patients with cancer, we must have at our fingertips the latest information that will bring hope, remission, and, potentially, survival. JCO's expansion to include all aspects of cancer research important to our practice and our patients will give us the information to move into the future.

AUTHOR'S DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST

The author indicated no potential conflicts of interest.





This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Disis, M. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Disis, M. L.

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2007 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online